Irfan A. Mirza

Resurrection Medical CenterChicago, Illinois - 60631 (847-965-3200) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS3
- SINCE2007

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012
Carcinoma, Renal Cell
Kidney Neoplasms
Bevacizumab
Temsirolimus
Sorafenib Tosylate



